- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02805478
Fat-Associated Cardiovascular Organ Dysfunction (FATCOR)
September 1, 2020 updated by: Haukeland University Hospital
This is an observational study of cardiovascular risk factors and arterial or cardiac function in subjects with overweight or obesity.
Subjects must be between 30 and 65 years of age, have a body mass index >27.0
kg/m2 and free from known heart disease and digestive or psychiatric disorders.
Study aims include identifying sex-differences in traditional cardiovascular risk factors and structural and functional abnormalities in arteries and the heart in subjects with overweight or obesity, and how this is influenced by physical fitness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
FATCOR is an observational study of women and men with overweight or obesity.
In particular prevalences of conventional cardiovascular risk factors and subclinical arterial or cardiac dysfunction are explored.
The study aims at identifying sex differences in presence and clustering of cardiovascular risk factors and presence of subclinical cardiovascular organ damage.
The influence of physical fitness on these factors will also be assessed.
All participants undergo extensive cardiovascular risk factor assessment including oral glucose tolerance test and ambulatory blood pressure recording.
Subclinical cardiovascular dysfunction is assessed by carotid and femoral vascular ultrasound, echocardiography and carotid-femoral pulse wave velocity using applanation tonometry.
Physical fitness is assessed from peak oxygen uptake during maximal exercise testing on a treadmill.
Study Type
Observational
Enrollment (Actual)
618
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bergen, Norway, 5021
- Haukeland University Hospital, Department of Heart Disease
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Norwegian women and men
Description
Inclusion Criteria:
- body mass index > 27.0 kg/m2
Exclusion Criteria:
- known heart disease
- digestive disorder
- psychiatric disorder
- unfamiliar with Norwegian language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Abnormal left ventricular geometry
Time Frame: At study baseline
|
Echocardiography
|
At study baseline
|
|
Dilated left atrium
Time Frame: At study baseline
|
Echocardiography
|
At study baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relation of physical fitness to prevalence of cardiovascular risk factors
Time Frame: At study baseline
|
Cardiopulmonary exercise
|
At study baseline
|
|
Relation of sex to prevalence of hypertension
Time Frame: At study baseline
|
Ambulatory blood pressure recording
|
At study baseline
|
|
Relation of sex to abnormal left ventricular geometry
Time Frame: At study baseline
|
Echocardiography
|
At study baseline
|
|
Relation of sex to arterial stiffness
Time Frame: At study baseline
|
Applanation tonometry
|
At study baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kjell Vikenes, MD PhD, Haukeland University Hospital, Department of Heart Disease
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Halland H, Lonnebakken MT, Saeed S, Midtbo H, Cramariuc D, Gerdts E. Does fitness improve the cardiovascular risk profile in obese subjects? Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):518-524. doi: 10.1016/j.numecd.2017.04.006. Epub 2017 Apr 26.
- Halland H, Lonnebakken MT, Pristaj N, Saeed S, Midtbo H, Einarsen E, Gerdts E. Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). Nutr Metab Cardiovasc Dis. 2018 Oct;28(10):1054-1060. doi: 10.1016/j.numecd.2018.06.014. Epub 2018 Jun 21.
- Halland H, Matre K, Einarsen E, Midtbo H, Saeed S, Pristaj N, Lonnebakken MT, Gerdts E. Effect of fitness on cardiac structure and function in overweight and obesity (the FATCOR study). Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):710-717. doi: 10.1016/j.numecd.2019.03.012. Epub 2019 Apr 3.
- Pristaj N, Saeed S, Midtbo H, Halland H, Matre K, Gerdts E. Covariables of Myocardial Function in Women and Men with Increased Body Mass Index. High Blood Press Cardiovasc Prev. 2020 Dec;27(6):579-586. doi: 10.1007/s40292-020-00418-6. Epub 2020 Oct 24.
- Herfindal B, Gerdts E, Kringeland EA, Saeed S, Midtbo H, Halland H. Concomitant hypertension is associated with abnormal left ventricular geometry and lower systolic myocardial function in overweight participants: the FAT associated CardiOvasculaR dysfunction study. J Hypertens. 2020 Jun;38(6):1158-1164. doi: 10.1097/HJH.0000000000002397.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 5, 2009
Primary Completion (Actual)
April 30, 2017
Study Completion (Actual)
April 30, 2017
Study Registration Dates
First Submitted
June 12, 2016
First Submitted That Met QC Criteria
June 17, 2016
First Posted (Estimate)
June 20, 2016
Study Record Updates
Last Update Posted (Actual)
September 4, 2020
Last Update Submitted That Met QC Criteria
September 1, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 189.08
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on There is no intervention
-
University of PennsylvaniaNovo Nordisk A/S; Albert Einstein College of Medicine; Northwestern University; Yale University and other collaboratorsRecruitingDiabetic Nephropathies | Diabetic GlomerulosclerosisUnited States
-
Göteborg UniversityNot yet recruitingCritical Illness | End of Life Care | Ethics
-
Peking University Third HospitalNot yet recruitingTransfusion-Associated Intestinal Injury,Ultrasound,Near-Infrared Spectroscopy
-
Leiden University Medical CenterHamilton Medical AGRecruitingCritical Illness | Intensive Care Unit | Mechanical VentilationNetherlands
-
University of California, San FranciscoRecruitingMucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VI | Wolman Disease | Pompe Disease Infantile-Onset | Mucopolysaccharidosis IV A | Mucopolysaccharidosis VII | Neuronopathic Gaucher DiseaseUnited States
-
Beaujon HospitalCompletedContrast-associated Acute Kidney InjuryFrance
-
Linkoeping UniversityCompleted
-
Stanford UniversityDuke University; National Institute of Environmental Health Sciences (NIEHS)CompletedPregnancy | Air PollutionUnited States
-
Northwell HealthWinterlight LabsCompletedSchizophrenia and Related DisordersUnited States
-
Danish Headache CenterCompletedMigraine | HeadacheDenmark